Mark C. Miller's most recent trade in Accelerate Diagnostics Inc was a trade of 50,886 Common Stock done . Disclosure was reported to the exchange on March 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 50,886 | 50,886 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 50,886 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 4,396 | 55,282 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 4,396 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 30 Sep 2021 | 13,022 | 39,062 (0%) | 0% | 7.7 | 100,009 | Common Stock |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 17,584 | 17,584 | - | - | Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 4,396 | 4,396 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 09 Apr 2021 | 13,020 | 26,040 (0%) | 0% | 7.7 | 99,994 | Common Stock |
| Accelerate Diagnostics Inc | Mark C. Miller | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 19 Feb 2021 | 13,020 | 13,020 (0%) | 0% | 7.7 | 99,994 | Common Stock |